Reduced 8-Gray compared to standard 12-Gray Total Body Irradiation for allogeneic transplantation in first remission acute lymphoblastic leukemia: a study of the Acute Leukemia Working Party of the EBMT

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Englisch

Erschienen in
In: HemaSphere, 7, 1, S. e812-

Ereignis
Veröffentlichung
(wo)
Augsburg
(wer)
Universität Augsburg
(wann)
2023
Ereignis
Veröffentlichung
(wo)
Philadelphia, Pennsylvania
(wer)
Ovid Technologies (Wolters Kluwer Health)
(wann)
2023
Urheber
Spyridonidis, Alexandros
Labopin, Myriam
Savani, Bipin
Giebel, Sebastian
Bug, Gesine
Schönland, Stefan
Kröger, Nicolaus
Stelljes, Matthias
Schroeder, Thomas
McDonald, Andrew
Blau, Igor-Wolfgang
Bornhäuser, Martin
Rovira, Montse
Bethge, Wolfgang
Neubauer, Andreas
Ganser, Arnold
Bourhis, Jean Henri
Edinger, Matthias
Lioure, Bruno
Wulf, Gerald
Schäfer-Eckart, Kerstin
Arat, Mutlu
Peric, Zinaida
Schmid, Christoph
Bazarbachi, Ali
Ciceri, Fabio
Nagler, Arnon
Mohty, Mohamad

DOI
10.1097/hs9.0000000000000812
URN
urn:nbn:de:bvb:384-opus4-1033031
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:47 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

Entstanden

  • 2023

Ähnliche Objekte (12)

Allogeneic transplant for mixed phenotype acute leukemia (MPAL): characteristics and outcome in the ALWP-EBMT Database

Allogeneic transplant for mixed phenotype acute leukemia (MPAL): characteristics and outcome in the ALWP-EBMT Database

Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT

Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT

Allogeneic hematopoietic stem cell transplantation for secondary acute myeloid leukemia: a report from the Acute Leukemia Working Party of the EBMT

Allogeneic hematopoietic stem cell transplantation for secondary acute myeloid leukemia: a report from the Acute Leukemia Working Party of the EBMT

Haploidentical versus unrelated allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia: a report on 1578 patients from the Acute Leukemia Working Party of the EBMT

Haploidentical versus unrelated allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia: a report on 1578 patients from the Acute Leukemia Working Party of the EBMT

Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT

Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT

Allogeneic stem cell transplantation using HLA-matched donors for acute myeloid leukemia with deletion 5q or monosomy 5 : : a study from the Acute Leukemia Working Party of the EBMT

Allogeneic stem cell transplantation using HLA-matched donors for acute myeloid leukemia with deletion 5q or monosomy 5 : : a study from the Acute Leukemia Working Party of the EBMT

Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT

Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT

Trends in the use of hematopoietic stem cell transplantation for adults with acute lymphoblastic leukemia in Europe: a report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Trends in the use of hematopoietic stem cell transplantation for adults with acute lymphoblastic leukemia in Europe: a report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Unrelated donor versus matched sibling donor in adults with acute myeloid leukemia in first relapse: an ALWP-EBMT study

Unrelated donor versus matched sibling donor in adults with acute myeloid leukemia in first relapse: an ALWP-EBMT study

The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years—a report from the EBMT acute leukemia working party

The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years—a report from the EBMT acute leukemia working party

Predictive limitations of hematopoietic stem cell transplantation associated mortality: a machine learning in-silico analysis of the EBMT - Acute Leukemia Working Party Registry

Predictive limitations of hematopoietic stem cell transplantation associated mortality: a machine learning in-silico analysis of the EBMT - Acute Leukemia Working Party Registry

Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Verbundene Objekte